INVICTUS ANNOUNCES AB LABORATORIES INC. RECEIVES AMENDED LICENSE
Vancouver, B.C., Sept. 11, 2019 (GLOBE NEWSWIRE) -- Vancouver, BC, September 11, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) is pleased to announce that AB Laboratories Inc. (“AB Labs”) a company which is a 50% owned subsidiary of Invictus has received their amended license from Health Canada to include the new 40,000 sq. ft. custom built cultivation facility located near Hamilton, Ontario.
As previously announced on June 26, 2019, AB Labs’ facility contains ten identical cultivation rooms capable of producing over 65 crops annually on a tightly controlled weekly production schedule. Five rooms have been propagated since receiving the amended license on August 30, 2019. The initial harvest is scheduled for November 1, 2019. The remaining rooms are expected to be propagated at a rate of one room per week over the next five weeks to ensure a reliable continuous production of cannabis for the recreational and medical markets.
Mr. Marc Ripa, Chief Operating Officer of Invictus and Chief Executive Officer of AB Labs and the other 50% owner of AB Labs stated, “AB Labs submitted the evidence package on June 4, 2019 and received the amended license from Health Canada in less than ninety days. I am extremely pleased with the efficiency of Health Canada in processing AB Labs’ documentation. The employees have been working extremely hard since receipt of the license to get the five rooms into production and are continuing to press on with the additional five rooms.”
Mr. Trevor Dixon, President and CEO of the Company said, “The completion of these ten rooms will double the Company’s volume of finished product going to market this year”.
For more information, please visit www.invictus-md.com.
Trevor Dixon
Chief Executive Officer
Investor Relations 1-844-800-6086